Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.3K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

3.7K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.7K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.2K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

2.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.2K
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

6.7K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
6.7K
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

423
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
423

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Household electricity consumption in Greece: A dataset based on socio-economic features.

Data in brief·2023
Same author

Information System for Symptom Diagnosis and Improvement of Attention Deficit Hyperactivity Disorder: Protocol for a Nonrandomized Controlled Pilot Study.

JMIR research protocols·2022
Same author

TP-DDI: Transformer-based pipeline for the extraction of Drug-Drug Interactions.

Artificial intelligence in medicine·2021
Same author

TransforMED: End-to-Εnd Transformers for Evidence-Based Medicine and Argument Mining in medical literature.

Journal of biomedical informatics·2021
Same author

EBM+: Advancing Evidence-Based Medicine via two level automatic identification of Populations, Interventions, Outcomes in medical literature.

Artificial intelligence in medicine·2020
Same author

FIFS: A data mining method for informative marker selection in high dimensional population genomic data.

Computers in biology and medicine·2017
Same journal

An Ultra-Lightweight Cross-scale Attention Mamba Network for Accurate Skin Lesion Segmentation.

IEEE journal of biomedical and health informatics·2026
Same journal

Explanation-Guided Reconstruction of Missing Clinical Features for Survival Prediction in Pancreatic Cancer.

IEEE journal of biomedical and health informatics·2026
Same journal

stDGCN: A dual-augmentation graph convolutional network for identifying spatial domains with attention mechanism.

IEEE journal of biomedical and health informatics·2026
Same journal

Patient-specific Biomechanical Investigation of Percutaneous Pulmonary Valves: Towards the Integration of Routinely Acquired Clinical Data and Fluid-structure Interaction Simulations.

IEEE journal of biomedical and health informatics·2026
Same journal

Cross-subject fMRI-to-Image with Visual-cortex 2D Representation and Pre-Training.

IEEE journal of biomedical and health informatics·2026
Same journal

PGCASurv: A Prior-Guided Cross-Attention Framework for Dynamic Survival Model with Longitudinal Data.

IEEE journal of biomedical and health informatics·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K

TransformDDI: The Transformer-Based Joint Multi-Task Model for End-to-End Drug-Drug Interaction Extraction.

Dimitrios Zaikis, Ioannis Vlahavas

    IEEE Journal of Biomedical and Health Informatics
    |March 3, 2025
    PubMed
    Summary
    This summary is machine-generated.

    TransformDDI, a novel Transformer-based model, enhances drug-drug interaction (DDI) identification from biomedical literature. It improves accuracy by jointly extracting drug entities and classifying interactions, outperforming existing methods.

    More Related Videos

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.4K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.1K

    Related Experiment Videos

    Last Updated: May 3, 2026

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    11.7K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.4K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.1K

    Area of Science:

    • Biomedical Informatics
    • Computational Linguistics
    • Pharmacovigilance

    Background:

    • Drug-Drug Interaction (DDI) identification is crucial for patient safety, aiming to prevent adverse drug effects.
    • The increasing volume of biomedical literature makes manual extraction of DDIs challenging and time-consuming.
    • Existing Machine Learning approaches for DDI extraction often suffer from error propagation due to pipelined task dependencies.

    Purpose of the Study:

    • To develop an advanced, end-to-end model for accurate and efficient extraction of DDIs from biomedical texts.
    • To address the limitations of current methods by integrating Named Entity Recognition and Relationship Classification in a joint framework.
    • To leverage domain knowledge and a Transformer architecture for improved DDI identification.

    Main Methods:

    • Proposed TransformDDI, an end-to-end Transformer-based joint multi-task model for DDI extraction.
    • Integrated domain knowledge and a shared parameter layer within a dynamic Language Model architecture.
    • Implemented a Dynamic Pair Attention Mechanism with task-specific focus and dynamic loss functions for variable output generation.

    Main Results:

    • The proposed TransformDDI model demonstrated significant improvements in DDI extraction accuracy.
    • Achieved state-of-the-art performance on the DDI Extraction 2013 benchmark corpus.
    • The joint multi-task approach effectively mitigated error propagation issues present in pipelined methods.

    Conclusions:

    • TransformDDI offers a robust and effective solution for automated DDI extraction from biomedical literature.
    • The model's architecture successfully integrates drug entity recognition and interaction classification.
    • This approach holds promise for enhancing drug safety monitoring and clinical decision support systems.